Vuzix (NASDAQ: VUZI) reported Q2 2026 revenue of $1.1 million, down 14% from $1.3 million a year earlier, while loss per common share narrowed to $0.09 from $0.10. Gross loss improved, but operating cash use increased to $6.6 million, leaving the company with $17.3 million in cash and no debt at quarter-end.
Core financial results
Revenue declined in both reported sales categories. Gross loss narrowed by $116,000 because cost of sales decreased by more than revenue in absolute dollar terms, although Vuzix continued to spend substantially more producing its goods and services than it generated in sales.
| Metric | Q2 2026 | Q2 2025 | Year-over-year change |
|---|---|---|---|
| Total revenue | $1.113 million | $1.296 million | Down 14% |
| Gross loss | $(0.645) million | $(0.761) million | Loss narrowed 15% |
| Operating loss | $(7.754) million | $(7.855) million | Loss narrowed 1% |
| Net loss | $(7.629) million | $(7.666) million | Loss narrowed less than 1% |
| Loss per common share | $(0.09) | $(0.10) | Narrowed by $0.01 |
| Net cash used in operations | $6.6 million | $4.8 million | Cash use increased about 38% |
Business performance
Product sales remained the company’s main revenue source but also recorded the larger decline. Engineering-services revenue decreased more moderately.
| Revenue category | Q2 2026 | Q2 2025 | Year-over-year change |
|---|---|---|---|
| Product sales | $884,000 | $1.045 million | Down 15% |
| Engineering services | $229,000 | $250,000 | Down 8% |
Operationally, Vuzix delivered initial Ultralite Pro glasses to Amazon for commercial testing while Amazon expanded M400 deployments across fulfillment centers. The Collins Aerospace program entered initial production deployments, and Vuzix delivered initial waveguide-based systems to a global automaker. The company also received initial and follow-on orders from Augmex. The release did not quantify the revenue contribution from these programs.
A narrower gross loss did not reduce cash burn
Research and development expense increased 20% to $3.1 million, primarily because of higher external product-development costs and increased salary and benefit expenses associated with additional headcount. Selling and marketing expense declined 11% to $1.2 million, largely because of lower non-cash stock-based compensation, while general and administrative expense decreased 3% to $2.7 million.
Lower selling, administrative, depreciation and amortization expenses offset most of the R&D increase, leaving total listed operating expenses at approximately $7.1 million in both periods. As a result, the smaller gross loss produced only a limited reduction in operating loss.
Cash flow moved in the opposite direction. Operating cash use rose by $1.8 million to $6.6 million even though the net loss was nearly unchanged. Vuzix ended June 30 with $17.3 million in cash and no current or long-term debt obligations, providing balance-sheet support but leaving cash consumption as an important operating consideration.
Management perspective
Management said demand for AI-based smart glasses is gaining momentum across enterprise and ODM/OEM markets as large companies develop strategies for deploying the technology. Vuzix plans to continue investing in waveguide innovation, manufacturing equipment and strategic relationships.
The company is configuring its waveguide operations so that one production line can support development while another handles volume production. Management believes this structure will allow Vuzix to work on more ODM/OEM, defense and waveguide programs simultaneously, but the current quarter’s revenue decline shows that deployment milestones have not yet translated into broader reported growth.
Recent insider transactions
The supplied insider data shows aggregate purchases of 88,236 shares across three transactions during the previous six months, compared with sales of 53,663 shares across three transactions. That produced net purchases of 34,573 shares, equivalent to 0.30% of shares, while total insider holdings were reported at 13.2 million shares.
The following individual sales had clear dates, prices and reported transaction values. These transactions do not, by themselves, establish insiders’ views about the company’s prospects.
| Date | Insider | Role | Transaction | Price per share | Reported value |
|---|---|---|---|---|---|
| May 26, 2026 | Paula Beck Whitten-Doolin | Director | Sale | $4.68 | $149,824 |
| May 21, 2026 | Timothy Heydenreich Harned | Director | Sale | $4.73 | $47,300 |
| March 4, 2026 | Christopher Iain Parkinson | Officer | Sale | $2.69 | $31,368 |
| December 22, 2025 | Christopher Iain Parkinson | Officer | Sale | $2.92 | $27,614 |
Risks investors need to watch
- Continued revenue contraction: Both product and engineering-services sales declined, indicating that announced customer programs have not yet offset weakness in existing revenue.
- Negative gross profit: Cost of sales remained above total revenue. Without better gross economics, revenue growth alone may not be enough to reduce operating losses materially.
- Higher cash consumption: Quarterly operating cash use increased to $6.6 million against a $17.3 million cash balance. Continued cash burn would reduce financial flexibility despite the absence of debt.
- Commercialization and investment timing: Vuzix is increasing R&D spending and investing in waveguide manufacturing while several customer programs remain in testing or initial deployment stages. The timing and scale of their conversion into recurring or volume revenue were not quantified.
Summary
Vuzix’s Q2 2026 results showed lower revenue and continued gross losses, while increased R&D investment limited improvement in operating profitability. Customer deployments and waveguide-manufacturing initiatives provide potential paths toward commercialization, but the central issues remain whether those programs can produce meaningful revenue and whether Vuzix can control operating cash consumption while continuing to invest.
Find out more